Injective INJ
Current Price
$3.02 +0.33%
$0.0800 Daily Range (2.65%)
$2.96$3.04
$43.64M Daily Volume
589 BTC
Vol/MktCap: 14.42%
Market Performance
0.08% Relative BTC Volume
The total volume of Injective is $43.64M over the past 24 hours, compared to $52.47B total Bitcoin volume.
Hourly Moving Average
Price Performance
+0.42% 1 Hour Change
$3.02 from $3.01
-0.20% 7 Day Change
-$0.0061 from $3.03
+3.25% 14 Day Change
$0.0983 from $2.92
-5.60% 30 Day Change
-$0.1692 from $3.19
All Time High
March 14, 2024
$52.62 -94.25%
-$49.59 vs. now
24H Change
1.21M USD +0.40%
16 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ AvailableRelative Supply Ratio
5.00 x BTC SupplyRelative Trade Volume
14.55M INJ
traded over past 24 hours
Conversion Tool
Injective AI Market Analysis
The trading volume stands at approximately 33.74 million, contributing to a volume-to-market cap ratio of 11.24%, which suggests reasonable liquidity. Moving averages are mixed; the 8 SMA at $2.98 shows a positive trend of 0.74%, while the 21 SMA at $3.01 indicates a minor decline of 0.17%, reflecting indecisiveness in market direction.
Momentum indicators show that the 1-hour RSI is at 44, signaling a potential bearish sentiment, while the 7-day RSI is neutral at 52. Over the past week, INJ has seen a minor decline of 0.48%, but the 14-day price change reflects a positive uptick of 4.58%, suggesting some recovery over a longer timeframe despite recent fluctuations.
Injective's all-time high is $52.62, achieved in March 2024, highlighting substantial room for price appreciation from current levels. However, the recent 30-day price change of -3.42% indicates ongoing bearish pressure, warranting caution for short-term traders.
Considering the current price action, mixed technical indicators, and recent performance trends, the recommendation for Injective (INJ) is a Hold. The market's short-term bearish sentiment, coupled with a potential recovery in the medium term, suggests that maintaining positions may be prudent while monitoring for clearer bullish signals.
Updated 271 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

A generational shift in wealth ownership is expected to reshape investment strategies, with Grayscale highlighting how digital assets could gain importance as younger investors…

The largest corporate ether holder posted a $3.8 billion quarterly loss as its pivot from mining to ETH accumulation continues.

Stablecoin liquidity sits idle on Ethereum, while Bitcoin moves within a tight range, leaving capital waiting for a clearer directional signal.

The ETH/BTC ratio hit its highest since January as Ethereum's network added 284,000 new users in Q1 and stablecoin supply reached a record $180 billion.